No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors
- 31 August 2005
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (12) , 1819-1823
- https://doi.org/10.1016/j.ejca.2005.04.035
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast CancerAmerican Journal of Human Genetics, 2002
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002
- Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityJournal of Medical Genetics, 2002
- Drosophila Chk2 is required for DNA damage‐mediated cell cycle arrest and apoptosisFEBS Letters, 2001
- DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2Science, 2000
- hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage responseNature, 2000
- A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damageProceedings of the National Academy of Sciences, 1999
- Heterogeneity in Breast Cancer and the Problem of Relevance of FindingsAnalytical Cellular Pathology, 1999
- Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein KinaseScience, 1998
- Epidemiology of cancer: global patterns and trendsToxicology Letters, 1998